Philips introduces next generation of Advanced Visualization
Workspace – IntelliSpace Portal 12 – with AI capabilities at RSNA
2020
November 30, 2020
- Next generation of Philips’ advanced radiology visualization
platform leverages image post-processing and artificial
intelligence (AI) to deliver quantitative clinical insights, drive
increased diagnostic confidence, simplify workflows, and reduce
time-to-report
- New features include AI algorithms for lung nodule detection,
cardiac functional analysis, and quantification of pulmonary
infiltrates associated with COVID-19 patients
- Intelligent, automated and connected multi-modality,
multi-vendor suite of applications supports follow-up and
communication across clinical care pathways
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced the next generation of Philips Advanced Visualization
Workspace – IntelliSpace Portal 12 for radiologists. Launched at
this year’s virtual Radiological Society of North America
Scientific Assembly and Annual Meeting (RSNA 2020), IntelliSpace
Portal features a robust set of new AI-assisted quantitative
assessment and automatic results generation features to support the
diagnostic workflow, including follow-up and communication across
cardiology, pulmonology, oncology and neurology. Its AI-assisted
pulmonary capabilities include the assessment of complex lung
conditions associated with COVID-19.
“In the COVID era, the automatic detection and characterization
of pulmonary infiltrates, especially in viral pneumonia, is very
important,” said Hans-Ulrich Kauczor, professor
and chairman of radiology at the University
of Heidelberg in Germany. “IntelliSpace
Portal’s AI-assisted quantitative assessment capabilities
allow general radiologists and residents on call to get the
necessary support to help identify COVID pneumonia, which is
differentiated from other diagnoses. This also plays a significant
role for longitudinal analysis and follow-up.“
“The immediate and complex long-term needs of COVID-19 patients,
combined with the growth of elective care, has highlighted the
continued need for advanced fully-integrated radiology solutions
that support efficient diagnosis, follow-up and communication
across multiple clinical domains,” said Calum Cunningham, General
Manager of Enterprise Diagnostic Informatics at Philips. “The new
generation of IntelliSpace Portal adds numerous AI-enabled features
that automatically generate quantitative measurements, simplify
workflows, and make radiology data available anywhere it’s
clinically relevant in an organization.”
Expanding its ecosystem for radiology solutions, new clinical
software packages [1] in cardiology, pulmonology, oncology and
neurology being launched with IntelliSpace Portal 12, several of
which have been integrated in collaboration with Pie Medical
Imaging BV or Riverain Technologies, include:
CardiologyMR Cardiac Analysis
– Pre-processing images to deliver AI-based right ventricle and
left ventricle segmentation to ensure accurate volumetric and
functional measurements, enabling completion of a full cardiac MRI
functional analysis in less than 5 minutes [2].
MR Caas™ 4D Flow Analysis – To reduce analysis
time and improve reliability of valvular flow quantification [3],
Caas [4] MR 4D Flow visualizes and quantifies blood flow patterns
in a patient’s heart and main arteries.
PulmonologyCT Pulmo Auto Results
[5] – Featuring AI algorithms trained on complex pulmonary
CT scans, including those of COVID-19 patients, CT Pulmo Auto
Results software performs automatic lung segmentation and lesion
segmentation, together with classification of ground glass
opacities/consolidation. Its automatically generated reports
include volume summaries and lesion distribution data to help in
the quantitative assessment of pulmonary infiltrates, enhancing
diagnostic confidence without increasing reading time.
OncologyCT ClearRead™ CAD Lung Nodule
Analysis [6] – featuring AI-based
detection and characterization for various nodule types including
solid, part-solid and ground-glass lung nodules, enabling to
perform nodule searches 26% faster and detect 29% of previously
missed nodules [7].
NeurologyCT Brain Perfusion
Analysis – IntelliSpace Portal 12 now supports automatic
brain perfusion measurements instantly available on PACS with the
option of automatically emailing perfusion results to a stroke
patient’s clinicians within two minutes to reduce door-to-needle
time.
Additional EnhancementsThe software also
includes a new photorealistic volume rendering [8]
technology using an interactive virtual light source to improve the
visualization of volumes in terms of their depth and relationship
to other key anatomies – enhancing its use as an educational and
communication tool.
Other enhancements in IntelliSpace Portal include workflow
innovations for vascular analysis to deliver faster results, new
automatic lesion segmentation propagation between time-points for
longitudinal tumor tracking, new CaasTM [4] myocardial strain
quantification software, and enhanced automatic capabilities for CT
coronaries analysis.
Philips Radiology Workflow Suite at RSNA 2020At
RSNA 2020, Philips will showcase an integrated suite of offerings
for the first time, introducing key solutions that come together to
enhance the entire radiology workflow to address the most pressing
operational challenges across diagnostic and interventional
radiology. Philips Advanced Visualization Workspace – IntelliSpace
Portal – is a key component for Image and data
interpretation within Philips Radiology Workflow Suite,
connecting patient data across departments to create
interoperability for greater clinical intelligence and analysis,
supported by AI-tools such as an algorithm for the detection of
COVID-19 lesions. Visit Philips Live at RSNA 2020 for more
information on Philips integrated workflow solutions to connect
data, technology and people across the diagnostic enterprise,
helping to redefine radiology workflow efficiencies.
Philips’ triple duty of careThe COVID-19
pandemic continues to highlight how interconnected the world’s
social, economic and environmental challenges are. Philips remains
fully focused on delivering against its triple duty of care:
meeting critical customer needs, safeguarding the health and safety
of its employees, and ensuring business continuity. As a
purpose-driven health technology company, Philips is applying its
innovation strength to improve the health and well-being of people.
The company is deeply committed to doing business responsibly and
sustainably, recently setting out a range of challenging new
environmental, social and governance targets.
[1] Some IntelliSpace Portal functionalities may not be
available in all territories.[2] Average RV/LV analysis time
measured on validation study 4.2 min +/- 0.4[3] V.P. Kamphuis et
al., Automated Cardiac Valve Tracking for Flow Quantification with
Four-dimensional Flow MRI, Radiology, 2019 Jan;290(1):70-78[4] Caas
is a trademark of Pie Medical Imaging BV.[5] The functionality may
not be available in all territories. In the United States of
America, the CT Pulmo Auto Results can only be used during the
National Emergency Concerning the Novel Coronavirus Disease
(COVID-19). The CT Pulmo Auto Results functionality is exempt from
premarket notification according to the FDA Guidance document for
Imaging Systems During the Coronavirus Disease 2019 (COVID-19), and
was therefore not cleared by the FDA. It is offered via a trial
license only for the duration of the national emergency, until
further notice.[6] ClearRead CT is a trademark of Riverain
Technologies.[7] ShihChung et al. AJR 2018; 210:480-488[8]
IntelliSpace Portal’s Photorealistic Volume Rendering is not
intended for diagnostic image review
For further information, please contact:
Kathy O’ReillyPhilips Global Press OfficeTel.: +1
978-221-8919E-mail : kathy.oreilly@philips.comTwitter:
@kathyoreilly
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2019
sales of EUR 19.5 billion and employs approximately 81,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- IntelliSpace Portal 12 Photorealistic Chest 3D Image
- IntelliSpace Portal 12 Photorealistic Vascular 3D Image
- IntelliSpace Portal 12 with AI Capabilities
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2024 to May 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From May 2023 to May 2024